Trial Profile
Comparison of Esmolol and Dexmedetomidine on Sympathetic Control During Intracranial Procedures
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Esmolol
- Indications Sedation
- Focus Therapeutic Use
- 25 Jul 2017 Planned End Date changed from 1 Aug 2016 to 1 Oct 2017.
- 25 Jul 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
- 30 Jul 2016 Planned End Date changed from 1 Dec 2015 to 1 Aug 2016.